| abstract |
The present invention is related to 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one derivatives of the general structural formula (I), where X is a carboxylic group COOH, m is 0, 1, 2 or 3; Y is a sulfonic group SO 3 H, n is 0, 1, 2 or 3; Z is an acid amide group L-NH 2 ; p is 0, 1, 2 or 3; K is a counterion selected from the list comprising H + , NH 4 + , Na + , K + , Li + , Mg 2+ , Ca 2+ , Zn 2+ , and Al 3+ ; s is the number of counterions providing neutral state of the molecule; R is a substituent selected from the list comprising CH 3 , C 2 H 5 , NO 2 , Cl, Br, F, CF 3 , CN, OH, OCH 3 , OC 2 H 5 , OCOCH 3 , OCN, SCN, NH 2 , and NHCOCH 3 ; w is 0, 1, 2, 3 or 4; and R 1 is a substituent selected from the list comprising H, CH 3 , C 2 H 5 , C 3 H 7 , i-C 3 H 7 , CH 2 CH 2 CH 2 CH 3 , CH(CH 3 )CH 2 CH 3 , CH 2 CH(CH 3 )CH 3 and C(CH 3 ) 3 and L is a linking group. |